Multiplex PCR using real time DNA amplification for the rapid detection and quantitation of HTLV I or II

Molecular and Cellular Probes

Volumn 17, Issue 2-3, 2003, Pages 59-68

  Estes, Michael C ^a   Sevall, J Sanders ^a  

^a Specialty Laboratories   (United States)

Author keywords

Biplex polymerase chain reaction; HTLV I II; Real time DNA amplification

Indexed keywords

DNA;

ACCURACY; ARTICLE; FLUORESCENCE; GENE AMPLIFICATION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN TISSUE; LONG TERMINAL REPEAT; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; RELIABILITY; SENSITIVITY AND SPECIFICITY; STANDARD; VIRUS DETECTION; VIRUS GENE; VIRUS TITRATION;

HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; MONOPLEX;

EID: 0037526285     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-8508(03)00002-1     Document Type: Article

References (28)

1. Poiesz B.J. Etiology of acute leukemia, molecular genetics and viral oncology. Wienik C.P.H., Camelos G.P., Dutcher J.P., Kyle R.A. Neoplastic diseases of the blood. 1995;159 Churchill Livingstone, New York.
2. Poiesz B.J., Papsidero L.D., Ehrlich G., et al. Prevalence of HTLV I associated T-cell Lymphoma. Am J Hematol. 66:2001;32-38.
3. Gessian A., Barin F., Vernant J.C., Gout O., Maurs L., Calender A., de Tge G. Antibodies to human T-cell lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet. 2:1985;407-410.
4. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV I associated myelopathy, a new clinical entity. Lancet. 1:1986;1031-1032.
5. Mochizuki M., Watanabe T., Yamaguchi K., Takatsuki K., Yoshimura K., Shirao M., Nakashima S., Mon K., Araki S., Miyata N. HTLV I uvetis: a distinct clinical entity caused by HTLV I. Jpn J Cancer Res. 83:1992;236-239.
6. LaGrenade L., Hanchard B., Fletcher V., Cranston B., Blattner W. Infective dermatitis of Jamaican children: marker for HTLV I infection. Lancet. 336:1990;1345-1347.
7. Nishioka K., Maruyama I., Sato K., Kitajima I., Nakajima Y., Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet. 1:1989;441.
8. Loughran T.P., Coyle T., Sherman M.P., et al. Detection of human T-cell leukemia/lumphoma virus type II in a patient with LGL leukemia. Blood. 80:1992;300-309.
9. Poiesz B., Dube D., Dube S., et al. HTLV-II associated CD8+ cutaneous T-cell lymphoma in an HIV-1 infected patient. N Engl J Med. 342:2000;930-936.
10. Yoshida M., et al. Increased replication of HTLV-I in HTLV-I associated myelopathy. Ann Neurol. 26:1989;331.
11. Gessian A., Saaal F., Gout O. High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indies, Guianese, and African patients with tropical spastic paraparesis. Blood. 15:1990;428-433.
12. Ono A., Ikeda E., Mochizuki M., Matsuokas M., Yamaguchi K., Sawada T., Yamane S., Tokudome S., Watanabe T. Provirus load in patients with human T-cell leukemia virus type 1 uveitis correlates with precedent Graves' disease and disease activities. Jpn J Cancer Res. 89:1998;608-614.
13. Nagai M., Usuku K., Matsumoto W., Kodama D., Takenouchi N., Moritoyo T., Hashiguchi S., Ichinose M., Bangham C.R., Izumo S., Osame M. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers,: high proviral load strongly predisposes to HAM/TSP. J Neurovirol. 4:1998;586-593.
14. Manns A., Miley W.J., Wilks R.J., Morgan O.S., Hanchard B., Wharfe G., Cranston B., Maloney E., Wells S.L., Blattner W.A., Waters D. Quantitative proviral DNA and antibody levels in the natural history of HTLV-l infection. J Infect Dis. 180:1999;1487-1493.
15. Miley W.J., Suryanarayana K., Manns A., Kubota R., Jacobson S., Lifson J.D., Waters D. Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load. AIDS Res Hum Retroviruses. 16:2000;665-675.
16. Etoh E., Yamaguchi K., Tokudome S., Watanabe T., Okayama T., Okayama A., Stuver S., Mueller N., Takatsuki K., Matsuoka M. Rapid quantification of HTLV I provirus load: detection of monoclonal proliferation of HTLVB-I infected cells among blood donors. Int J Cancer. 81:1999;859-864.
17. Dehee A., Cesaire Desire N., Lezin A., Bourdonne O., Bera O., Plumella Y., Smadja D., Nicolas J.C. Quantitation of HTLV I proviral load by a TaqMan real-time PVR assay. J Virol Methods. 102:2002;37-51.
18. Markoulatos P., Siafakas N., Moncany M. Multiplex polymerase chain reaction: a practical approach. J Clin Lab Anal. 16:2002;47-51.
19. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol cholorform extraction. Anal Biochem. 162:1987;156-159.
20. Longo M.C., Berninger M.S., Hartley J.L. Uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene. 93:1990;125-128.
21. Meijerink J., Mandigers C., van de Locht L., Tönnissen E., Goodsaid F., Raemaekers J. A novel method to compensate for different amplication efficiencies between patient DNA samples in quantitative real-time PCR. J Mol Diag. 3:2001;55-61.
22. Zucker-Franklin D., Pancake B.A. Human T-cell lymphotrophic virus type I tax among American blood donors. Clin Diagn Lab Immunol. 5:1998;831-835.
23. Cowan E.P., Nemo G.J., Williams A.E., Alexander R.K., Vallejo A., Hewlett I.K., Kak R.B., Dezzutti C.S., Gallahan K., Pancake B.A., Zucker-Franklin D., McCurdy P.R., Tabor E. Absence of human T-lymphotropic virus Type I tax sequences in a population of normal blood donors in the Baltimore, MD/Washington DC area: results from a multicenter study. Transfusion. 39:1999;904-909.
24. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986-994.
25. Bustin S.A. Absolute quantitfication of mRNA using real-time reverse transcriptase polymerase chain reaction assay. J Mol Endocrinal. 25:2000;169-193.
26. Berger A., Preiser W. Viral genome quantification as a tool for improving management: the example of HIV, HBV, HCV and CMV. J Antimicrob Chemother. 49:2002;713-721.
27. Galeno H., Ramirez E., Cartier L. HTLV-I provirus in sernegatve Chilean patients with tropical spastic paraparesis. Lancet. 2:1996;1170.
28. Berger A., Preeiser W. Viral genome quantification as a tool for improving patient management: the example of HIV, HBV, HCV, and CMV. J Antimicrob Chemo. 49:2002;713-721.